Volatile Anesthetics

This forum made possible through the generous support of SDN members, donors, and sponsors. Thank you.

Dryacku

Member
10+ Year Member
5+ Year Member
15+ Year Member
Joined
Jan 22, 2006
Messages
186
Reaction score
1
Hey Im having a hard time understanding volatile anesthestics... I have read multiple books, but still have a hard time grasping how to adminster them to pt's as far as dosing?

Also how are they metabolized??? is it mostly evaporations or hoffman effect??? liver or kidneys??? and how much???

also which to use when??? ( i know i can find the answer to this on my own, but if you have preference)....


thanks for any help
 
Alright i figured out it is nimbex that undergoes hoffman effect... but any help with the rest of the questions
 
Nimbex and atracurium are both eliminated via Hofmans and are NMR. The volatile agents have varying degrees of liver Metabolism but most are just breathed off. A good way to memorize metabolism is to remember the number 2.

Halothane - 20%
Enflurane - 2%
Iso - .2%
Des - .02%
Sevo - 2%

You may find varying numbers in different texts but in general I have seen most close to these numbers. What isnt metabolized via CYP450's is breathed out unchanged which is why we can absorb the CO2 and allow rebreathing of the gases. Think you need to read more text though. Which texts have you read. If you dont feel like you got much from what you read perhaps you should try another text and see what the different author has to say. As far as which one the give you should understand how the gases effect major systems, take into account comorbid DZ's, length of surgery, how fast you need the pt to wake up ect ect.
 
Volatile anesthetics are the inhaled anesthetics, specifically iso, sevo, and des, that we administer. you're talking about neuromuscular blocking agents. There's succinylcholine, the only depolarizing NMB, and then the nondepolarizers. Best way to think about them is to divide them into their groups according to chemical structures. There are the steroid derivatives (panc, roc, vec, pip) and the benzylisoquinilines (atra, cis-atra, miv[going off the market, apparently]). There are some common traits that you can remember based on what group they belong to (e.g., BIQs cause histamine release), but as far as onset/duration, specific side effects, and metabolism, I'm afraid you have to memorize. I recommend the chapter from Morgan/Mikhail (Lange) - ch9 in the new edition.
 
Mechanism of Action of Inhaled Anesthetics

Inhaled anesthetics act in different ways at the level of the central nervous system. They may disrupt normal synaptic transmission by interfering with the release of neurotransmitters from presynaptic nerve terminal (enhance or depress excitatory or inhibitory transmission), by altering the re-uptake of neurotransmitters, by changing the binding of neurotransmitters to the post-synaptic receptor sites, or by influencing the ionic conductance change that follows activation of the post-synaptic receptor by neurotransmitters. Both, pre- and postsynaptic effects have been found.

Direct interaction with the neuronal plasma membrane is very likely, but indirect action via production of a second messenger also remains possible. The high correlation between lipid solubility and anesthetic potency suggests that inhalation anesthetics have a hydrophobic site of action. Inhalation agents may bind to both membrane lipids and proteins. It is at this time not clear which of the different theories are most likely to be the main mechanism of action of inhalation anesthetics.

The Meyer-Overton theory describes the correlation between lipid solubility of inhaled anesthetics and MAC and suggests that anesthesia occurs when a sufficient number of inhalation anesthetic molecules dissolve in the lipid cell membrane. The Meyer-Overton rule postulates that the number of molecules dissolved in the lipid cell membrane and not the type of inhalation agent causes anesthesia. Combinations of different inhaled anesthetics may have additive effects at the level of the cell membrane.

However, the Meyer-Overton theory does not describe why anesthesia occurs. Mullins expanded the Meyer-Overton rule by adding the so-called Critical Volume Hypothesis. He stated that the absorption of anesthetic molecules could expand the volume of a hydrophobic region within the cell membrane and subsequently distort channels necessary for sodium ion flux and the development of action potentials necessary for synaptic transmission. The fact that anesthesia occurs with significant increase in volume of hydrophobic solvents and is reversible by compressing the volume of the expanded hydrophobic region of the cell membrane supports Mullins Critical Volume Hypothesis.

The protein receptor hypothesis postulates that protein receptors in the central nervous system are responsible for the mechanism of action of inhaled anesthetics. This theory is supported by the steep dose response curve for inhaled anesthetics. However, it remains unclear if inhaled agents disrupt ion flow through membrane channels by an indirect action on the lipid membrane, via a second messenger, or by direct and specific binding to channel proteins.

Another theory describes the activation of Gamma-Aminobutyric acid (GABA) receptors by the inhalation anesthetics. Volatile agents may activate GABA channels and hyperpolarize cell membranes. In addition, they may inhibit certain calcium channels and therefore prevent release of neurotransmitters and inhibit glutamate channels. Volatile anesthetics share therefore common cellular actions with other sedative, hypnotic or analgesic drugs.

Each of the mentioned theories describes a unitary theory of narcosis. They all concentrate more or less on an unique site of action for inhaled anesthetics. The true mechanism of action of volatile anesthetics may be a combination of two or more such theories described as multisite action hypothesis.


Courtesy of your friendly local CRNA website. 🙂

P.S. Nimbex is a nondepolarizing skeletal muscle relexant, not a volatile
anesthetic. Good luck with school and your future endeavors.
 
The bottom line is that nobody really knows how volatile anesthetic gases work. There are a couple of major theories listed above, but they are only theories and may all be wrong. Each gas has unique characteristics making it advantageous in certain situations, but they all do the same thing. There is a little liver/kidney metabolism for these, but in order for the patient to wake up, you have to stop administering it and breathe it off.
 
Top